James R. Neal
Director · Processa Pharmaceuticals, Inc.
IndividualBuying only
- 2024
- Jul 29, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James R. Neal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Russell Skibsted - $42K in PCSA purchases and sales in the last 12 months
- George K. Ng - $39K in PCSA purchases and sales in the last 12 months
- Wendy Guy - $33K in PCSA purchases and sales in the last 12 months
- David Young - $32K in PCSA purchases and sales in the last 12 months
- Patrick Lin - $28K in PCSA purchases and sales in the last 12 months
- Sian Bigora - $21K in PCSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James R. Neal?
James R. Neal is a corporate insider, tracked as Director of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James R. Neal submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has James R. Neal been buying or selling stock?
Recorded transactions: 5 open-market purchases ($4K) and 0 open-market sales across all tracked filings.
